BSECompany Update3d ago · 17 Aug 2026, 03:36 pm
Announcement under Regulation 30 (LODR)- Newspaper Publication for the Unaudited Standalone and Consolidated Financial Results for the Qtr ended 30.06.2026
Medicamen Biotech Ltd-$ · 531146
✦ AI SummaryResults
Medicamen Biotech Ltd has announced the publication of its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Medicamen Biotech Ltd-$ - 531146 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Attachments (1)
📄pdf
Download →
f6a8ac24-8eb5-473b-a1b5-71edf196c960.pdf
View document text
Ref: STEX/Results/Published-2026-27 Date: 17.08.2026
BSE Limited National Stock Exchange of India Ltd
Floor 25, P J Towers Exchange Plaza, C-1, Block G,
Dalal Street Bandra Kurla Complex, Bandra (E)
Mumbai-400001 Mumbai – 400 051
BSE Code-531146 NSE Code: MEDICAMEQ
Sub. : Copy of Publication for Un-audited Financial Results for the quarter ended on June
30, 2026
Dear Sir,
Pursuant to regulation 30 & 47 of SEBI (Listing obligation and disclosure requirements)
Regulations, 2015 (“the Regulations”), please find enclosed newspaper cutting with regard to the
publication of extract of Un-audited Financial Results of the Company for the quarter ended on
June 30, 2026 approved by the Board of Directors at their Meeting held on 14.08.2026.
The copy of the results published in the Financial Express and Jansatta dated 15.08.2026 is
enclosed.
This is for your information and records.
Kindly acknowledge the receipt.
Thanking You,
Yours truly,
For Medicamen Biotech Limited
Parul Choudhary
Company Secretary
ACS-44157
Encl: As above.